Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesTargeting the prostate-specific membrane antigen for prostate cancer therapy
Immunotherapy, 04/29/09
Buhler P et al. - The prostate-specific membrane antigen is a cell-surface glycoprotein that is highly and specifically expressed on prostate epithelial cells and strongly upregulated in prostate cancer at all stages. These characteristics make it an attractive target for antibody-based imaging and therapies and the first anti-prostate-specific membrane antigen agents have already entered clinical trials. The proposed strategies include targeted toxins and radiotherapeutics as well as immunotherapeutic agents and vaccines.
Related Articles
Hormone Therapy Can Help Some with Prostate Cancer
MedLinePlus, 11/04/09
Relevance Score: 83%
The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer
BJU International, 11/09/09
Relevance Score: 82%
Radiation Therapy Technique Successfully Treats Pain In Patients With Advanced Cancer
ScienceDaily, 11/04/09
Relevance Score: 82%
Prostate cancer: Quality of life after radiation and androgen deprivation
NCP Urology, 10/13/09
Relevance Score: 82%
Estimated dose to the rectum and colon in prostate cancer patients treated with exclusive radiation therapy presenting a secondary colorectal malignancy
Clinical Oncology, 10/07/09
Relevance Score: 82%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/07/09
Small-for-size liver graft injury--impact on tumor behavior
Transplantation Reviews, 12/07/09
IL-13 from Th2-type cells suppresses induction of antigen-specific Th1 immunity in a T-cell lymphoma
International Immunology, 12/03/09
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Meta-Analyses Qualify Metzincins and Related Genes as Acute Rejection Markers in Renal Transplant Patients
American Journal of Transplantation, 12/07/09
Measuring vs estimating glomerular filtration rate in kidney transplantation
Transplantation Reviews, 12/07/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/07/09
Sponsor
Article Search
Sponsor